Why the study?
Does a routine strategy of rhythm control reduce death from cardiovascular causes in patients with atrial fibrillation and congestive heart failure?
Does a routine strategy of rhythm control reduce death from cardiovascular causes in patients with atrial fibrillation and congestive heart failure?
A routine rhythm-control strategy does not reduce cardiovascular mortality compared to rate control in patients with concurrent atrial fibrillation and congestive heart failure.
Answers are grounded in this paper and cite their sources.
Establishes rate control as a safe primary strategy in concurrent AF and HF; challenges the historical.
In patients with atrial fibrillation and congestive heart failure, a routine strategy of rhythm control does not reduce the rate of death from cardiovascular causes, as compared with a rate-control strategy. (ClinicalTrials.gov number, NCT00597077.)
No takes yet. Share an insight, caveat, or question.
Roy et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: